Company Overview of Koronis Pharma, Inc.
Koronis Pharma, Inc. develops antiviral therapeutics based on Viral Decay Acceleration mechanism. It develops KP-1461 for the treatment of HIV virus; and products for the treatment of antiviral infections. The company was founded in 1998 and is based in Seattle, Washington.
800 Fifth Avenue
Seattle, WA 98104
Founded in 1998
Key Executives for Koronis Pharma, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
To contact Koronis Pharma, Inc., please visit www.koronispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.